Kawasaki disease epidemiology and demographics: Difference between revisions
No edit summary |
|||
| Line 10: | Line 10: | ||
CDC uses hospital discharge data, a passive KS surveillance system, and special studies to describe the incidence and epidemiology of KS in the United States. The KS surveillance system has been maintained by CDC since 1976 and is based on voluntary reporting of KS cases by health care providers and local and state health authorities. A standardized case report form is used to collect information on patients. | CDC uses hospital discharge data, a passive KS surveillance system, and special studies to describe the incidence and epidemiology of KS in the United States. The KS surveillance system has been maintained by CDC since 1976 and is based on voluntary reporting of KS cases by health care providers and local and state health authorities. A standardized case report form is used to collect information on patients. | ||
For epidemiologic surveillance, CDC defines a case of KS as illness in a patient with fever of 5 or more days duration (or fever until the date of administration of intravenous immunoglobulin if it is given before the fifth day of fever), and the presence of at least 4 of the following 5 clinical signs: | For epidemiologic surveillance, CDC defines a case of KS as illness in a patient with fever of 5 or more days duration (or fever until the date of administration of intravenous immunoglobulin if it is given before the fifth day of fever), and the presence of at least 4 of the following 5 clinical signs:<ref name="pmid20204087">{{cite journal |vauthors=Assadian A, Assadian O, Simon A, Kramer A |title=Infection control consequences - early Staphylococcal Scalded Skin Syndrome or Kawasaki Syndrome? |journal=GMS Krankenhhyg Interdiszip |volume=4 |issue=2 |pages=Doc05 |date=December 2009 |pmid=20204087 |pmc=2831247 |doi=10.3205/dgkh000130 |url=}}</ref> | ||
*Rash | *Rash | ||
*Cervical lymphadenopathy (at least 1.5 cm in diameter) | *Cervical lymphadenopathy (at least 1.5 cm in diameter) | ||
Revision as of 16:03, 2 April 2018
|
Kawasaki disease Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
American Roentgen Ray Society Images of Kawasaki disease epidemiology and demographics |
|
Risk calculators and risk factors for Kawasaki disease epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
Kawasaki disease occurs worldwide, with the highest incidence in Japan, and it most often affects boys and younger children. KS may have a winter-spring seasonality, and community-wide outbreaks have been reported occasionally. In the continental United States, population-based and hospitalization studies have estimated an incidence of KS ranging from 9 to 19 per 100,000 children younger than 5 years of age. Approximately 4248 hospitalizations for Kawasaki disease, of which 3277 (77%) were for children under 5 years of age, were estimated among children younger than 18 years of age in the United States in the year 2000.
Epidemiology and Demographics
Kawasaki disease occurs worldwide, with the highest incidence in Japan, and it most often affects boys and younger children. KS may have a winter-spring seasonality, and community-wide outbreaks have been reported occasionally. In the continental United States, population-based and hospitalization studies have estimated an incidence of KS ranging from 9 to 19 per 100,000 children younger than 5 years of age. Approximately 4248 hospitalizations for Kawasaki disease, of which 3277 (77%) were for children under 5 years of age, were estimated among children younger than 18 years of age in the United States in the year 2000.[1]
CDC uses hospital discharge data, a passive KS surveillance system, and special studies to describe the incidence and epidemiology of KS in the United States. The KS surveillance system has been maintained by CDC since 1976 and is based on voluntary reporting of KS cases by health care providers and local and state health authorities. A standardized case report form is used to collect information on patients.
For epidemiologic surveillance, CDC defines a case of KS as illness in a patient with fever of 5 or more days duration (or fever until the date of administration of intravenous immunoglobulin if it is given before the fifth day of fever), and the presence of at least 4 of the following 5 clinical signs:[2]
- Rash
- Cervical lymphadenopathy (at least 1.5 cm in diameter)
- Bilateral conjuctival injection
- Oral mucosal changes
- Peripheral extremity changes.
Patients whose illness does not meet the above KS case definition but who have fever and coronary artery abnormalities are classified as having atypical or incomplete KS.
Incidence
By far, the highest incidence of Kawasaki disease occurs in Japan (175 per 100,000), though its incidence in the United States is increasing. Kawasaki disease is predominantly a disease of young children, with 80% of patients younger than 5 years of age. Additional risk factors in the United States include Asian race and male sex.
References
- ↑ "About Kawasaki Disease | Kawasaki Disease | CDC".
- ↑ Assadian A, Assadian O, Simon A, Kramer A (December 2009). "Infection control consequences - early Staphylococcal Scalded Skin Syndrome or Kawasaki Syndrome?". GMS Krankenhhyg Interdiszip. 4 (2): Doc05. doi:10.3205/dgkh000130. PMC 2831247. PMID 20204087.